Tower Research Capital (TRC)’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $943K | Buy |
38,301
+18,897
| +97% | +$437K | 0.02% | 653 |
|
|
2026
Q1 | $464K | Sell |
19,404
-27,921
| -59% | -$683K | 0.01% | 963 |
|
|
2025
Q4 | $1.07M | Buy |
47,325
+34,400
| +266% | +$749K | 0.03% | 492 |
|
|
2025
Q3 | $260K | Buy |
12,925
+12,834
| +14,103% | +$215K | 0.01% | 1283 |
|
|
2025
Q2 | $1.3K | Sell |
91
-1,878
| -95% | -$21.9K | ﹤0.01% | 4832 |
|
|
2025
Q1 | $20.7K | Sell |
1,969
-1,957
| -50% | -$22.1K | ﹤0.01% | 2929 |
|
|
2024
Q4 | $47.5K | Sell |
3,926
-14,762
| -79% | -$193K | ﹤0.01% | 2588 |
|
|
2024
Q3 | $275K | Sell |
18,688
-4,691
| -20% | -$65.4K | 0.01% | 1331 |
|
|
2024
Q2 | $337K | Buy |
23,379
+16,669
| +248% | +$266K | 0.01% | 1655 |
|
|
2024
Q1 | $109K | Buy |
6,710
+498
| +8% | +$7.79K | ﹤0.01% | 1778 |
|
|
2023
Q4 | $92.6K | Buy |
6,212
+3,906
| +169% | +$44.2K | ﹤0.01% | 2705 |
|
|
2023
Q3 | $25.9K | Sell |
2,306
-4,242
| -65% | -$49.3K | ﹤0.01% | 3143 |
|
|
2023
Q2 | $65.9K | Sell |
6,548
-14,802
| -69% | -$137K | ﹤0.01% | 2354 |
|
|
2023
Q1 | $201K | Buy |
21,350
+16,956
| +386% | +$200K | 0.01% | 1372 |
|
|
2022
Q4 | $53K | Sell |
4,394
-46,957
| -91% | -$585K | ﹤0.01% | 2300 |
|
|
2022
Q3 | $638K | Buy |
51,351
+34,022
| +196% | +$595K | 0.01% | 952 |
|
|
2022
Q2 | $340K | Sell |
17,329
-26,776
| -61% | -$634K | 0.01% | 1388 |
|
|
2022
Q1 | $1.15M | Sell |
44,105
-14,667
| -25% | -$391K | 0.01% | 733 |
|
|
2021
Q4 | $1.67M | Buy |
58,772
+17,390
| +42% | +$541K | 0.03% | 489 |
|
|
2021
Q3 | $1.32M | Buy |
41,382
+4,763
| +13% | +$160K | 0.03% | 401 |
|
|
2021
Q2 | $1.27M | Sell |
36,619
-9,103
| -20% | -$300K | 0.03% | 502 |
|
|
2021
Q1 | $1.35M | Buy |
45,722
+39,051
| +585% | +$1.2M | 0.02% | 625 |
|
|
2020
Q4 | $204K | Buy |
6,671
+1,182
| +22% | +$36.1K | 0.01% | 1691 |
|
|
2020
Q3 | $153K | Sell |
5,489
-52,231
| -90% | -$1.32M | ﹤0.01% | 2805 |
|
|
2020
Q2 | $1.24M | Buy |
57,720
+55,706
| +2,766% | +$1.23M | 0.05% | 397 |
|
|
2020
Q1 | $45K | Buy |
+2,014
| New | +$55.2K | ﹤0.01% | 1338 |
|
|
2019
Q4 | – | Sell |
-1,997
| Closed | -$53K | – | 3736 |
|
|
2019
Q3 | $53K | Sell |
1,997
-2,163
| -52% | -$64.9K | ﹤0.01% | 1755 |
|
|
2019
Q2 | $141K | Sell |
4,160
-991
| -19% | -$32.2K | 0.01% | 1008 |
|
|
2019
Q1 | $165K | Sell |
5,151
-225
| -4% | -$6.92K | 0.01% | 1208 |
|
|
2018
Q4 | $170K | Sell |
5,376
-1,032
| -16% | -$33.8K | 0.01% | 749 |
|
|
2018
Q3 | $224K | Buy |
+6,408
| New | +$225K | 0.02% | 918 |
|
Other funds holding ELAN
Tower Research Capital (TRC)'s ELAN Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Elanco Animal Health (ELAN) stake by 97% in Q2 2026, buying an estimated $437K and bringing the position to 38,301 shares worth $943K. The position accounts for 0.02% of the portfolio, ranked #653.
Tower Research Capital (TRC) first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.67M in Q4 2021. 521 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Tower Research Capital (TRC) held 38,301 shares of Elanco Animal Health worth $943K as of Q2 2026.
- Tower Research Capital (TRC) bought 18,897 Elanco Animal Health shares in Q2 2026, an estimated $437K.
- Elanco Animal Health made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #653 holding.
- Tower Research Capital (TRC) first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Tower Research Capital (TRC)'s Elanco Animal Health position peaked at $1.67M in Q4 2021.
- 521 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.